Table of Contents EMEA (Europe, Middle East and Africa) Parkinson's Disease Drug Market Report 2018 1 Parkinson's Disease Drug Overview 1.1 Product Overview and Scope of Parkinson's Disease Drug 1.2 Classification of Parkinson's Disease Drug 1.2.1 EMEA Parkinson's Disease Drug Market Size (Sales) Comparison by Type (2013-2025) 1.2.2 EMEA Parkinson's Disease Drug Market Size (Sales) Market Share by Type (Product Category) in 2017 1.2.3 Sinemet-CR 1.2.4 Trastal 1.2.5 Madopar 1.2.6 COMT Inhibitor 1.2.7 Other 1.3 EMEA Parkinson's Disease Drug Market by Application/End Users 1.3.1 EMEA Parkinson's Disease Drug Sales (Volume) and Market Share Comparison by Application (2013-2025) 1.3.2 Under 40 Years Old 1.3.3 40-65 Years Old 1.3.4 Above 65 Years Old 1.4 EMEA Parkinson's Disease Drug Market by Region 1.4.1 EMEA Parkinson's Disease Drug Market Size (Value) Comparison by Region (2013-2025) 1.4.2 Europe Status and Prospect (2013-2025) 1.4.3 Middle East Status and Prospect (2013-2025) 1.4.4 Africa Status and Prospect (2013-2025) 1.5 EMEA Market Size (Value and Volume) of Parkinson's Disease Drug (2013-2025) 1.5.1 EMEA Parkinson's Disease Drug Sales and Growth Rate (2013-2025) 1.5.2 EMEA Parkinson's Disease Drug Revenue and Growth Rate (2013-2025) 2 EMEA Parkinson's Disease Drug Competition by Manufacturers/Players/Suppliers, Region, Type and Application 2.1 EMEA Parkinson's Disease Drug Market Competition by Players/Manufacturers 2.1.1 EMEA Parkinson's Disease Drug Sales Volume and Market Share of Major Players (2013-2018) 2.1.2 EMEA Parkinson's Disease Drug Revenue and Share by Players (2013-2018) 2.1.3 EMEA Parkinson's Disease Drug Sale Price by Players (2013-2018) 2.2 EMEA Parkinson's Disease Drug (Volume and Value) by Type/Product Category 2.2.1 EMEA Parkinson's Disease Drug Sales and Market Share by Type (2013-2018) 2.2.2 EMEA Parkinson's Disease Drug Revenue and Market Share by Type (2013-2018) 2.2.3 EMEA Parkinson's Disease Drug Sale Price by Type (2013-2018) 2.3 EMEA Parkinson's Disease Drug (Volume) by Application 2.4 EMEA Parkinson's Disease Drug (Volume and Value) by Region 2.4.1 EMEA Parkinson's Disease Drug Sales and Market Share by Region (2013-2018) 2.4.2 EMEA Parkinson's Disease Drug Revenue and Market Share by Region (2013-2018) 2.4.3 EMEA Parkinson's Disease Drug Sales Price by Region (2013-2018) 3 Europe Parkinson's Disease Drug (Volume, Value and Sales Price), by Players, Countries, Type and Application 3.1 Europe Parkinson's Disease Drug Sales and Value (2013-2018) 3.1.1 Europe Parkinson's Disease Drug Sales Volume and Growth Rate (2013-2018) 3.1.2 Europe Parkinson's Disease Drug Revenue and Growth Rate (2013-2018) 3.2 Europe Parkinson's Disease Drug Sales and Market Share by Type 3.3 Europe Parkinson's Disease Drug Sales and Market Share by Application 3.4 Europe Parkinson's Disease Drug Sales Volume and Value (Revenue) by Countries 3.4.1 Europe Parkinson's Disease Drug Sales Volume by Countries (2013-2018) 3.4.2 Europe Parkinson's Disease Drug Revenue by Countries (2013-2018) 3.4.3 Germany Parkinson's Disease Drug Sales and Growth Rate (2013-2018) 3.4.4 France Parkinson's Disease Drug Sales and Growth Rate (2013-2018) 3.4.5 UK Parkinson's Disease Drug Sales and Growth Rate (2013-2018) 3.4.6 Russia Parkinson's Disease Drug Sales and Growth Rate (2013-2018) 3.4.7 Italy Parkinson's Disease Drug Sales and Growth Rate (2013-2018) 3.4.8 Benelux Parkinson's Disease Drug Sales and Growth Rate (2013-2018) 4 Middle East Parkinson's Disease Drug (Volume, Value and Sales Price), by Region, Type and Application 4.1 Middle East Parkinson's Disease Drug Sales and Value (2013-2018) 4.1.1 Middle East Parkinson's Disease Drug Sales Volume and Growth Rate (2013-2018) 4.1.2 Middle East Parkinson's Disease Drug Revenue and Growth Rate (2013-2018) 4.2 Middle East Parkinson's Disease Drug Sales and Market Share by Type 4.3 Middle East Parkinson's Disease Drug Sales and Market Share by Application 4.4 Middle East Parkinson's Disease Drug Sales Volume and Value (Revenue) by Countries 4.4.1 Middle East Parkinson's Disease Drug Sales Volume by Countries (2013-2018) 4.4.2 Middle East Parkinson's Disease Drug Revenue by Countries (2013-2018) 4.4.3 Saudi Arabia Parkinson's Disease Drug Sales and Growth Rate (2013-2018) 4.4.4 Israel Parkinson's Disease Drug Sales and Growth Rate (2013-2018) 4.4.5 UAE Parkinson's Disease Drug Sales and Growth Rate (2013-2018) 4.4.6 Iran Parkinson's Disease Drug Sales and Growth Rate (2013-2018) 5 Africa Parkinson's Disease Drug (Volume, Value and Sales Price) by Players, Countries, Type and Application 5.1 Africa Parkinson's Disease Drug Sales and Value (2013-2018) 5.1.1 Africa Parkinson's Disease Drug Sales Volume and Growth Rate (2013-2018) 5.1.2 Africa Parkinson's Disease Drug Revenue and Growth Rate (2013-2018) 5.2 Africa Parkinson's Disease Drug Sales and Market Share by Type 5.3 Africa Parkinson's Disease Drug Sales and Market Share by Application 5.4 Africa Parkinson's Disease Drug Sales Volume and Value (Revenue) by Countries 5.4.1 Africa Parkinson's Disease Drug Sales Volume by Countries (2013-2018) 5.4.2 Africa Parkinson's Disease Drug Revenue by Countries (2013-2018) 5.4.3 South Africa Parkinson's Disease Drug Sales and Growth Rate (2013-2018) 5.4.4 Nigeria Parkinson's Disease Drug Sales and Growth Rate (2013-2018) 5.4.5 Egypt Parkinson's Disease Drug Sales and Growth Rate (2013-2018) 5.4.6 Algeria Parkinson's Disease Drug Sales and Growth Rate (2013-2018) 6 EMEA Parkinson's Disease Drug Manufacturers/Players Profiles and Sales Data 6.1 Merck 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Parkinson's Disease Drug Product Type, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Merck Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.1.4 Main Business/Business Overview 6.2 Akorn 6.2.1 Company Basic Information, Manufacturing Base and Competitors 6.2.2 Parkinson's Disease Drug Product Type, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Akorn Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.2.4 Main Business/Business Overview 6.3 GSK 6.3.1 Company Basic Information, Manufacturing Base and Competitors 6.3.2 Parkinson's Disease Drug Product Type, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 GSK Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.3.4 Main Business/Business Overview 6.4 Novartis 6.4.1 Company Basic Information, Manufacturing Base and Competitors 6.4.2 Parkinson's Disease Drug Product Type, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Novartis Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.4.4 Main Business/Business Overview 6.5 Boehringer Ingelheim 6.5.1 Company Basic Information, Manufacturing Base and Competitors 6.5.2 Parkinson's Disease Drug Product Type, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Boehringer Ingelheim Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.5.4 Main Business/Business Overview 6.6 Teva Pharmaceutical 6.6.1 Company Basic Information, Manufacturing Base and Competitors 6.6.2 Parkinson's Disease Drug Product Type, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Teva Pharmaceutical Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.6.4 Main Business/Business Overview 6.7 Abbvie 6.7.1 Company Basic Information, Manufacturing Base and Competitors 6.7.2 Parkinson's Disease Drug Product Type, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Abbvie Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.7.4 Main Business/Business Overview 6.8 Kyowa Hakko Kirin Pharma 6.8.1 Company Basic Information, Manufacturing Base and Competitors 6.8.2 Parkinson's Disease Drug Product Type, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.8.4 Main Business/Business Overview 6.9 Astellas Pharma 6.9.1 Company Basic Information, Manufacturing Base and Competitors 6.9.2 Parkinson's Disease Drug Product Type, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Astellas Pharma Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.9.4 Main Business/Business Overview 6.10 Desitin Arzneimittel 6.10.1 Company Basic Information, Manufacturing Base and Competitors 6.10.2 Parkinson's Disease Drug Product Type, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Desitin Arzneimittel Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.10.4 Main Business/Business Overview 6.11 Endo Pharmaceuticals 6.12 F.Hoffmann-La Roche 6.13 H.Lundbeck 6.14 Valeant 6.15 Apokyn 6.16 Orion 6.17 Stada Arzneimittel 6.18 US WorldMeds 6.19 Valeant Pharmaceuticals 7 Parkinson's Disease Drug Manufacturing Cost Analysis 7.1 Parkinson's Disease Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Parkinson's Disease Drug 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Parkinson's Disease Drug Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Parkinson's Disease Drug Major Manufacturers in 2017 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 EMEA Parkinson's Disease Drug Market Forecast (2018-2025) 11.1 EMEA Parkinson's Disease Drug Sales, Revenue and Price Forecast (2018-2025) 11.1.1 EMEA Parkinson's Disease Drug Sales and Growth Rate Forecast (2018-2025) 11.1.2 EMEA Parkinson's Disease Drug Revenue and Growth Rate Forecast (2018-2025) 11.1.3 EMEA Parkinson's Disease Drug Price and Trend Forecast (2018-2025) 11.2 EMEA Parkinson's Disease Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.3 Europe Parkinson's Disease Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.4 Middle Eastt Parkinson's Disease Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.5 Africa Parkinson's Disease Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.6 EMEA Parkinson's Disease Drug Sales Forecast by Type (2018-2025) 11.7 EMEA Parkinson's Disease Drug Sales Forecast by Application (2018-2025) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Parkinson's Disease Drug Figure EMEA Parkinson's Disease Drug Sales Volume (K Units) by Type (2013-2025) Figure EMEA Parkinson's Disease Drug Sales Volume Market Share by Type (Product Category) in 2017 Figure Sinemet-CR Product Picture Figure Trastal Product Picture Figure Madopar Product Picture Figure COMT Inhibitor Product Picture Figure Other Product Picture Figure EMEA Parkinson's Disease Drug Sales Volume (K Units) by Application (2013-2025) Figure EMEA Sales Market Share of Parkinson's Disease Drug by Application in 2017 Figure Under 40 Years Old Examples Table Key Downstream Customer in Under 40 Years Old Figure 40-65 Years Old Examples Table Key Downstream Customer in 40-65 Years Old Figure Above 65 Years Old Examples Table Key Downstream Customer in Above 65 Years Old Figure EMEA Parkinson's Disease Drug Market Size (Million USD) by Region (2013-2025) Figure Europe Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2013-2025) Figure Europe Parkinson's Disease Drug Revenue (Million USD) Status and Forecast by Countries Figure Middle East Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2013-2025) Figure Middle East Parkinson's Disease Drug Revenue (Million USD) Status and Forecast by Countries Figure Africa Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2013-2025) Figure Africa Parkinson's Disease Drug Revenue (Million USD) Status and Forecast by Countries Figure EMEA Parkinson's Disease Drug Sales Volume and Growth Rate (2013-2025) Figure EMEA Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2013-2025) Figure EMEA Parkinson's Disease Drug Market Major Players Product Sales Volume (K Units) (2013-2018) Table EMEA Parkinson's Disease Drug Sales Volume (K Units) of Major Players (2013-2018) Table EMEA Parkinson's Disease Drug Sales Share by Players (2013-2018) Figure 2017 Parkinson's Disease Drug Sales Share by Players Figure 2017 Parkinson's Disease Drug Sales Share by Players Figure EMEA Parkinson's Disease Drug Market Major Players Product Revenue (Million USD) (2013-2018) Table EMEA Parkinson's Disease Drug Revenue (Million USD) by Players (2013-2018) Table EMEA Parkinson's Disease Drug Revenue Share by Players (2013-2018) Table 2017 EMEA Parkinson's Disease Drug Revenue Share by Players Table 2017 EMEA Parkinson's Disease Drug Revenue Share by Players Table EMEA Parkinson's Disease Drug Sale Price (USD/Unit) by Players (2013-2018) Table EMEA Parkinson's Disease Drug Sales (K Units) and Market Share by Type (2013-2018) Table EMEA Parkinson's Disease Drug Sales Share by Type (2013-2018) Figure Sales Market Share of Parkinson's Disease Drug by Type (2013-2018) Figure EMEA Parkinson's Disease Drug Sales Market Share by Type (2013-2018) Table EMEA Parkinson's Disease Drug Revenue (Million USD) and Market Share by Type (2013-2018) Table EMEA Parkinson's Disease Drug Revenue Share by Type (2013-2018) Figure Revenue Market Share of Parkinson's Disease Drug by Type in 2017 Table EMEA Parkinson's Disease Drug Sale Price (USD/Unit) by Type (2013-2018) Table EMEA Parkinson's Disease Drug Sales (K Units) and Market Share by Application (2013-2018) Table EMEA Parkinson's Disease Drug Sales Share by Application (2013-2018) Figure Sales Market Share of Parkinson's Disease Drug by Application (2013-2018) Figure EMEA Parkinson's Disease Drug Sales Market Share by Application in 2017 Table EMEA Parkinson's Disease Drug Sales (K Units) and Market Share by Region (2013-2018) Table EMEA Parkinson's Disease Drug Sales Share by Region (2013-2018) Figure Sales Market Share of Parkinson's Disease Drug by Region (2013-2018) Figure EMEA Parkinson's Disease Drug Sales Market Share in 2017 Table EMEA Parkinson's Disease Drug Revenue (Million USD) and Market Share by Region (2013-2018) Table EMEA Parkinson's Disease Drug Revenue Share by Region (2013-2018) Figure Revenue Market Share of Parkinson's Disease Drug by Region (2013-2018) Figure EMEA Parkinson's Disease Drug Revenue Market Share Regions in 2017 Table EMEA Parkinson's Disease Drug Sales Price (USD/Unit) by Region (2013-2018) Figure Europe Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Europe Parkinson's Disease Drug Revenue and Growth Rate (2013-2018) Table Europe Parkinson's Disease Drug Sales (K Units) by Type (2013-2018) Table Europe Parkinson's Disease Drug Market Share by Type (2013-2018) Figure Europe Parkinson's Disease Drug Market Share by Type in 2017 Table Europe Parkinson's Disease Drug Sales (K Units) by Application (2013-2018) Table Europe Parkinson's Disease Drug Market Share by Application (2013-2018) Figure Europe Parkinson's Disease Drug Market Share by Application in 2017 Table Europe Parkinson's Disease Drug Sales (K Units) by Countries (2013-2018) Table Europe Parkinson's Disease Drug Sales Market Share by Countries (2013-2018) Figure Europe Parkinson's Disease Drug Sales Market Share by Countries (2013-2018) Figure Europe Parkinson's Disease Drug Sales Market Share by Countries in 2017 Table Europe Parkinson's Disease Drug Revenue (Million USD) by Countries (2013-2018) Table Europe Parkinson's Disease Drug Revenue Market Share by Countries (2013-2018) Figure Europe Parkinson's Disease Drug Revenue Market Share by Countries (2013-2018) Figure Europe Parkinson's Disease Drug Revenue Market Share by Countries in 2017 Figure Germany Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure France Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure UK Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Russia Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Italy Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Benelux Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Middle East Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Middle East Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2013-2018) Table Middle East Parkinson's Disease Drug Sales (K Units) by Type (2013-2018) Table Middle East Parkinson's Disease Drug Market Share by Type (2013-2018) Figure Middle East Parkinson's Disease Drug Market Share by Type (2013-2018) Table Middle East Parkinson's Disease Drug Sales (K Units) by Applications (2013-2018) Table Middle East Parkinson's Disease Drug Market Share by Applications (2013-2018) Figure Middle East Parkinson's Disease Drug Sales Market Share by Application in 2017 Table Middle East Parkinson's Disease Drug Sales Volume (K Units) by Countries (2013-2018) Table Middle East Parkinson's Disease Drug Sales Volume Market Share by Countries (2013-2018) Figure Middle East Parkinson's Disease Drug Sales Volume Market Share by Countries in 2017 Table Middle East Parkinson's Disease Drug Revenue (Million USD) by Countries (2013-2018) Table Middle East Parkinson's Disease Drug Revenue Market Share by Countries (2013-2018) Figure Middle East Parkinson's Disease Drug Revenue Market Share by Countries (2013-2018) Figure Middle East Parkinson's Disease Drug Revenue Market Share by Countries in 2017 Figure Saudi Arabia Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Israel Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure UAE Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Iran Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Africa Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Africa Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2013-2018) Table Africa Parkinson's Disease Drug Sales (K Units) by Type (2013-2018) Table Africa Parkinson's Disease Drug Sales Market Share by Type (2013-2018) Figure Africa Parkinson's Disease Drug Sales Market Share by Type (2013-2018) Figure Africa Parkinson's Disease Drug Sales Market Share by Type in 2017 Table Africa Parkinson's Disease Drug Sales (K Units) by Application (2013-2018) Table Africa Parkinson's Disease Drug Sales Market Share by Application (2013-2018) Figure Africa Parkinson's Disease Drug Sales Market Share by Application (2013-2018) Table Africa Parkinson's Disease Drug Sales Volume (K Units) by Countries (2013-2018) Table Africa Parkinson's Disease Drug Sales Market Share by Countries (2013-2018) Figure Africa Parkinson's Disease Drug Sales Market Share by Countries (2013-2018) Figure Africa Parkinson's Disease Drug Sales Market Share by Countries in 2017 Table Africa Parkinson's Disease Drug Revenue (Million USD) by Countries (2013-2018) Table Africa Parkinson's Disease Drug Revenue Market Share by Countries (2013-2018) Figure Africa Parkinson's Disease Drug Revenue Market Share by Countries (2013-2018) Figure Africa Parkinson's Disease Drug Revenue Market Share by Countries in 2017 Figure South Africa Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Nigeria Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Egypt Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Algeria Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Table Merck Parkinson's Disease Drug Basic Information List Table Merck Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Merck Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Merck Parkinson's Disease Drug Sales Market Share in EMEA (2013-2018) Figure Merck Parkinson's Disease Drug Revenue Market Share in EMEA (2013-2018) Table Akorn Parkinson's Disease Drug Basic Information List Table Akorn Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Akorn Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Akorn Parkinson's Disease Drug Sales Market Share in EMEA (2013-2018) Figure Akorn Parkinson's Disease Drug Revenue Market Share in EMEA (2013-2018) Table GSK Parkinson's Disease Drug Basic Information List Table GSK Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure GSK Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure GSK Parkinson's Disease Drug Sales Market Share in EMEA (2013-2018) Figure GSK Parkinson's Disease Drug Revenue Market Share in EMEA (2013-2018) Table Novartis Parkinson's Disease Drug Basic Information List Table Novartis Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Novartis Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Novartis Parkinson's Disease Drug Sales Market Share in EMEA (2013-2018) Figure Novartis Parkinson's Disease Drug Revenue Market Share in EMEA (2013-2018) Table Boehringer Ingelheim Parkinson's Disease Drug Basic Information List Table Boehringer Ingelheim Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Boehringer Ingelheim Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Boehringer Ingelheim Parkinson's Disease Drug Sales Market Share in EMEA (2013-2018) Figure Boehringer Ingelheim Parkinson's Disease Drug Revenue Market Share in EMEA (2013-2018) Table Teva Pharmaceutical Parkinson's Disease Drug Basic Information List Table Teva Pharmaceutical Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Teva Pharmaceutical Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Teva Pharmaceutical Parkinson's Disease Drug Sales Market Share in EMEA (2013-2018) Figure Teva Pharmaceutical Parkinson's Disease Drug Revenue Market Share in EMEA (2013-2018) Table Abbvie Parkinson's Disease Drug Basic Information List Table Abbvie Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Abbvie Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Abbvie Parkinson's Disease Drug Sales Market Share in EMEA (2013-2018) Figure Abbvie Parkinson's Disease Drug Revenue Market Share in EMEA (2013-2018) Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Basic Information List Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales Market Share in EMEA (2013-2018) Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Revenue Market Share in EMEA (2013-2018) Table Astellas Pharma Parkinson's Disease Drug Basic Information List Table Astellas Pharma Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Astellas Pharma Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Astellas Pharma Parkinson's Disease Drug Sales Market Share in EMEA (2013-2018) Figure Astellas Pharma Parkinson's Disease Drug Revenue Market Share in EMEA (2013-2018) Table Desitin Arzneimittel Parkinson's Disease Drug Basic Information List Table Desitin Arzneimittel Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Desitin Arzneimittel Parkinson's Disease Drug Sales (K Units) and Growth Rate (2013-2018) Figure Desitin Arzneimittel Parkinson's Disease Drug Sales Market Share in EMEA (2013-2018) Figure Desitin Arzneimittel Parkinson's Disease Drug Revenue Market Share in EMEA (2013-2018) Table Endo Pharmaceuticals Parkinson's Disease Drug Basic Information List Table F.Hoffmann-La Roche Parkinson's Disease Drug Basic Information List Table H.Lundbeck Parkinson's Disease Drug Basic Information List Table Valeant Parkinson's Disease Drug Basic Information List Table Apokyn Parkinson's Disease Drug Basic Information List Table Orion Parkinson's Disease Drug Basic Information List Table Stada Arzneimittel Parkinson's Disease Drug Basic Information List Table US WorldMeds Parkinson's Disease Drug Basic Information List Table Valeant Pharmaceuticals Parkinson's Disease Drug Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Parkinson's Disease Drug Figure Manufacturing Process Analysis of Parkinson's Disease Drug Figure Parkinson's Disease Drug Industrial Chain Analysis Table Raw Materials Sources of Parkinson's Disease Drug Major Manufacturers in 2017 Table Major Buyers of Parkinson's Disease Drug Table Distributors/Traders List Figure EMEA Parkinson's Disease Drug Sales (K Units) and Growth Rate Forecast (2018-2025) Figure EMEA Parkinson's Disease Drug Revenue and Growth Rate Forecast (2018-2025) Figure EMEA Parkinson's Disease Drug Price (USD/Unit) and Trend Forecast (2018-2025) Table EMEA Parkinson's Disease Drug Sales (K Units) Forecast by Region (2018-2025) Figure EMEA Parkinson's Disease Drug Sales Market Share Forecast by Region (2018-2025) Table EMEA Parkinson's Disease Drug Revenue (Million USD) Forecast by Region (2018-2025) Figure EMEA Parkinson's Disease Drug Revenue Market Share Forecast by Region (2018-2025) Table Europe Parkinson's Disease Drug Sales (K Units) Forecast by Countries (2018-2025) Figure Europe Parkinson's Disease Drug Sales Market Share Forecast by Countries (2018-2025) Table Europe Parkinson's Disease Drug Revenue (Million USD) Forecast by Countries (2018-2025) Figure Europe Parkinson's Disease Drug Revenue Market Share Forecast by Countries (2018-2025) Table Middle East Parkinson's Disease Drug Sales (K Units) Forecast by Countries (2018-2025) Figure Middle East Parkinson's Disease Drug Sales Market Share Forecast by Countries (2018-2025) Table Middle East Parkinson's Disease Drug Revenue (Million USD) Forecast by Countries (2018-2025) Figure Middle East Parkinson's Disease Drug Revenue Market Share Forecast by Countries (2018-2025) Table Africa Parkinson's Disease Drug Sales (K Units) Forecast by Countries (2018-2025) Figure Africa Parkinson's Disease Drug Sales Market Share Forecast by Countries (2018-2025) Table Africa Parkinson's Disease Drug Revenue (Million USD) Forecast by Countries (2018-2025) Figure Africa Parkinson's Disease Drug Revenue Market Share Forecast by Countries (2018-2025) Table EMEA Parkinson's Disease Drug Sales (K Units) Forecast by Type (2018-2025) Figure EMEA Parkinson's Disease Drug Sales Market Share Forecast by Type (2018-2025) Table EMEA Parkinson's Disease Drug Sales (K Units) Forecast by Application (2018-2025) Figure EMEA Parkinson's Disease Drug Sales Market Share Forecast by Application (2018-2025) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources